Correlation Between Stoke Therapeutics and Savara

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Savara at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Savara into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Savara Inc, you can compare the effects of market volatilities on Stoke Therapeutics and Savara and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Savara. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Savara.

Diversification Opportunities for Stoke Therapeutics and Savara

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Stoke and Savara is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Savara Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Savara Inc and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Savara. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Savara Inc has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Savara go up and down completely randomly.

Pair Corralation between Stoke Therapeutics and Savara

Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.77 times more return on investment than Savara. However, Stoke Therapeutics is 1.77 times more volatile than Savara Inc. It trades about 0.09 of its potential returns per unit of risk. Savara Inc is currently generating about 0.0 per unit of risk. If you would invest  460.00  in Stoke Therapeutics on September 2, 2024 and sell it today you would earn a total of  751.00  from holding Stoke Therapeutics or generate 163.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Stoke Therapeutics  vs.  Savara Inc

 Performance 
       Timeline  
Stoke Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Savara Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Savara Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Stoke Therapeutics and Savara Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stoke Therapeutics and Savara

The main advantage of trading using opposite Stoke Therapeutics and Savara positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Savara can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Savara will offset losses from the drop in Savara's long position.
The idea behind Stoke Therapeutics and Savara Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes